Swiss Firm Starts Research Into SARS Vaccine

Vaccination News Home Page            Scandals            subscribe Vaccination NewsLetter

http://www.advanceformrc.com/common/editorial/editorial.aspx?CC=14306

Swiss Firm Starts Research Into SARS Vaccine
 
Swiss vaccines firm Berna Biotech said on Tuesday it had started research into the development of a vaccine against severe acute respiratory syndrome, the flu-like disease that has killed 464 people since it broke out last year, Reuters reports. 

The firm said that after four months to six months it might be able to determine the likelihood of success, what was needed in terms of resources to make a vaccine, and how long it would take before a vaccine would reach the market. U.S. scientists last month asked more than a dozen American and European health care companies, including Berna, to help develop a vaccine to protect against SARS. 

Officials have said it could take years to come up with a safe and effective vaccine.

 

Copyright ©2003 Merion Publications
2900 Horizon Drive, King of Prussia, PA 19406 • 800-355-5627
Publishers of ADVANCE Newsmagazines
www.advanceweb.com

 

Vaccination News Home Page

 

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.